String of Turds


Anonymous

Guest
Dapa, now 2.5 billion for nothing in hep C, Apixa delayed, insider trading, overpaid for Amylin. Desperation leads companies and people to make foolish decisions.

Lamberto, you're rocking - keep up the great work and we'll give you another 11 million dollar raise this year.

What a fucking joke.
 

Who needs licensing opportunities when BMS development efforts are leading to great drugs like Nulojix. Sure the payback will be slow. But sales may hit $5 million this year. Peak sales are probably like $25 million. So we will start to see a real profit there by approximately 2037. Good stuff. BMS R&D is hitting pay-dirt everywhere it turns. Elliott Sigal what was your compensation last year? Close to $10 million? Seems about right. Keep up the great work.
 


Write your reply...